Compare Charles River Laboratories Intl. Inc (CRL) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Tidewater Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Tidewater Inc trades at $85.42 (market cap $4.21B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 3.4× Tidewater Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Tidewater Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Tidewater Inc for 26 Days on average.
| CRL | TDW | |
|---|---|---|
Market Cap | $14.23B | $4.21B |
Volume | 1,176,885 | 590,005 |
Sector | Health | Energy |
52-Week High | $310.77 | $100.61 |
52-Week Low | $149.93 | $47.29 |
Typical Hold Time | 33 Days | 26 Days |
Enterprise Value | $17.06B | $4.25B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $301.79, up 0.5% with strong analyst support (73% buy ratings) and a $305.50 consensus target. The stock shows bullish technical momentum above key support levels, though fundamentals reveal challenges with negative net income margins (-5.96%) and elevated P/E ratio (684.85). Recent quarterly earnings beats and a new 2030 growth strategy provide optimism, but profitability concerns persist amid flat revenue trends.
The outlook balances near-term technical strength against fundamental headwinds. Investment opportunity lies in execution of the 5-7% growth target and $300M savings plan, while risks include sustained negative profitability, high debt levels ($2.24B), and margin pressure. Current price near resistance at $304 suggests limited upside without fundamental improvement.
Tidewater (TDW) trades at $85.42, up 2.42% with bullish technical indicators and strong institutional interest. The company maintains solid profitability with 18.34% net margin and 19.49% ROE, though recent quarterly earnings have missed expectations. Recent acquisition of Wilson Sons Ultratug expands offshore services capabilities, while BlackRock's $503 million investment signals confidence in long-term prospects.
TDW presents a mixed outlook with analyst consensus target of $105.50 offering 23% upside potential, but faces execution risks from recent earnings misses and Middle East operational costs. The stock's valuation at 17.18 P/E appears reasonable given growth prospects, though investors should monitor quarterly performance consistency and integration of recent acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
